Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideCVSCVS Health
FinDog View：Bullish
LLYLilly (Eli)
FinDog View：Bullish
| Metric | CVS | LLY |
|---|
| Close | 91.72 | 1,137.82 |
| Market Cap | $117B | $1.07T |
| 1M | −2.44% | −3.83% |
| P/E (TTM) | 24.4 | 39.9 |
| Forward P/E | 13.2 | 28.5 |
| P/E 5-Yr Percentile | 65 | 6 |
| P/S | 0.3 | 13.4 |
| P/B | 1.5 | 31.5 |
| Dividend Yield | 3.49% | 0.75% |
| Latest Quarter Revenue | $106B | $23.0B |
| Revenue YoY | +7.3% | +47.7% |
| Gross Margin | 44.5% | 85.8% |
| Latest Quarter EPS | 2.31 | 7.94 |
| Avg Post-Earnings Move | ±2.3% | ±3.5% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.91% | 1.12% |
| 90-Day Net Insider Buying | — | −$16.0M |
CVS · Revenue, Last 8 Quarters ($B)
LLY · Revenue, Last 8 Quarters ($B)
